August 19, 2014: As if things couldn’t get more competitive in East Cambridge’s office and lab market: Drug giant Amgen Inc. is on the prowl for another 150,000 square feet of space.
August 19, 2014: Amgen announced that a Phase 3 study of AMG 416 met its primary and all secondary endpoints.
August 19, 2014: Allergan's CFO, Jeff Edwards, will be stepping down, after which Jim Hindman, a 30-year company veteran, will assume the position of CFO. The changing of the guard is happening in the midst of Allergan’s battle to prevent a hostile takeover by Valeant.
August 19, 2014: Dermira, announced that it has completed a $51 million Series C round of financing. Bay City Capital, New Enterprise Associates and Canaan Partners were some of the many existing investors who took part in the financing round.